Sponsored Sessions

Rewriting Autoimmunity: New Immunologic Insights Transforming T1D Therapy Development

Sponsored by Breakthrough T1D

Thursday, April 16, 2026
7:00–8:00 AM

151

Chairs:

  • Gregory Golden, Breakthrough T1D
  • Joshua Vieth, Breakthrough T1D


Speakers

  • Elly Puckett, Univ. of Kansas Med. Ctr.
  • Tyler Jenkins, Vanderbilt Univ.
  • Jacquelyn Nestor, Harvard Univ.
  • Erin Maule, Univ. of Pennsylvania


This symposium will highly how emerging insights are reshaping our understanding of type 1 diabetes (T1D) pathogenesis and therapeutic opportunity. Speakers will highlight how recent research advances are positioning T1D as a both a proving ground for targeted immune intervention and a model for organ-specific autoimmunity more broadly.


The Immunology Podcast Presents: Emerging Therapies for Solid Tumors 

Friday April 17, 2026
11:00 AM–12:00 PM

157AB

Co-Hosts

  • Brenda Raud, The Immunology Podcast 
  • Jason Goldsmith, The Immunology Podcast 


Guests:

  • Charles Sentman, Dartmouth College, USA 
  • Giulia Escobar, Massachusetts General Hospital


Join the Immunology Podcast for a live recording on emerging immunotherapies for solid tumors. Hosts Brenda and Jason will be joined by Dr. Charles Sentman, Director of the Center for Synthetic Immunity at Dartmouth College, and Dr. Giulia Escobar, Director of Pre-Clinical Research at Massachusetts General Hospital. Together, they’ll explore new strategies aimed at overcoming the unique challenges of treating solid tumors, from engineering more effective immune cells to navigating the tumor microenvironment. The discussion will highlight recent advances in preclinical and translational research and what they could mean for the future of cancer immunotherapy.